Clinical Trials in Austin

Showing 801-820 of 15,205 trials

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

NCT07526974

A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.

Subcutaneous Fat

Caliway Biopharmaceuticals Co., Ltd.320 participantsStarted Oct 2026

Encinitas, California, United States • Aventura, Florida, United States • Alpharetta, Georgia, United States +11 more locations

Active Not RecruitingNA< 1 mile

SIMPLAAFY Clinical Trial

NCT06521463

The primary objective is to demonstrate the safety and effectiveness of two monotherapy regimens versus dual antiplatelet (DAPT) therapy following post-implant with the WATCHMAN FLX Pro device in a commercial clinical setting.

Atrial FibrillationStrokeBleeding

Boston Scientific Corporation1,857 participantsStarted Oct 2024

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +84 more locations

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

SIMPLAAFY Clinical Trial

Find Trials by Condition in Austin

A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

A Study of ZW251 in Participants With Advanced Solid Tumors

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

A Study of XMT-1660 in Participants With Solid Tumors

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)